hrp0094fc10.2 | Thyroid | ESPE2021
Lucie Levaillant
, German
, Almashanu
, De Vries Liat
, Gil Merav
, Halloun Rana
, Haim Alon
, Eyal Ori
, Magid Yael
, Levi Floris
, Pivko-Levi Dikla
, Nir Judith
, Pinhas-Hamiel Orit
, Tenenbaum-Rakover Yardena
, Natacha Bouhours-Nouet
, Frederic Illouz
, Nathalie Bouzamondo
, Patrice Rodien
, Delphine Prunier-Mirebeau
, Regis Coutant
Background: More than half of newborns with central congenital hypothyroidism (C-CH) have moderate-to-severe hypothyroidism in the neonatal phase, requiring immediate thyroxine therapy to prevent brain damage. The Israeli newborn screening for CH is based on the measurement of total T4 (TT4) followed by TSH measurement. However, when TSH is within the normal range the physicians are not informed of the results and therefore the diagnosis of C-CH and initiation...